Followers | 2543 |
Posts | 250735 |
Boards Moderated | 34 |
Alias Born | 05/06/2014 |
![](https://investorshub.advfn.com/uicon/477208.png?cb=1464790659)
Thursday, February 11, 2016 3:14:00 PM
Source: InvestorsHub NewsWire
Progressive Care Slated to Present at SeeThru Equity Conference in Miami
MIAMI, FL -- February 11, 2016 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces that it will be presenting at the SeeThru Equity & Brewer Group 2nd Annual Innovations and Investor Conference on February 22, 2016.
SeeThru Equity is an unaffiliated corporate research and access company providing unbiased research and analysis to various investor information platforms such as Thompson Reuters, CapitalIQ, etc. The Conference, which brings company visibility to microcap investors, sponsors, and professionals, will be held at the South Beach Ritz Carlton on Monday, February 22, 2016 at 8:00 AM. Progressive Care will deliver a 30 minute presentation at 9:30 AM about the development of the company, its fundamentals, and its growth agenda for the future. Management will stay on site for a short time afterward for Q&A and 1x1 meetings.
"We are excited to showcase our company at the SeeThru Equity Conference and the opportunity to interact with the investment community face-to-face. We look forward to answering questions and highlighting the Companys many achievements," stated S. Parikh Mars, CEO.
About Progressive Care
Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Companys expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words anticipate, believe, estimate, upcoming, plan, target, intend and expect and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact
Armen Karapetyan
Senior Advisor Business Development
Recent RXMD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 07:54:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 04:38:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 04:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:40:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:34:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:20:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:40:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:37:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:35:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 04:14:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:54:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:51:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:49:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 07:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 09:34:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 09:33:46 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM